CervoMed
CRVO
12 hedge funds and large institutions have $1.86M invested in CervoMed in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
20% more funds holding
Funds holding: 10 → 12 (+2)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
26% less capital invested
Capital invested by funds: $2.51M → $1.86M (-$650K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$108K |
| 2 |
Millennium Management
New York
|
+$72.4K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$43.4K |
| 4 |
Goldman Sachs
New York
|
+$41.4K |
| 5 |
ST
Smithfield Trust
Pittsburgh,
Pennsylvania
|
+$4.14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$193K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$6.21K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SRCM
1
Swift Run Capital Management
Charlottesville,
Virginia
| $1.15M | – | – | – |
|
|
WTC
2
WhitTier Trust Company
Reno,
Nevada
| $229K | – | – | – |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $214K | +$43.4K | +21 | +22% |
|
|
VF
4
Virtu Financial
New York
| $97K | +$108K | +52 | New |
|
|
5
Millennium Management
New York
| $66K | +$72.4K | +35 | New |
|
|
6
Goldman Sachs
New York
| $37K | +$41.4K | +20 | New |
|
7
BlackRock
New York
| $26K | – | – | – |
|
|
SFM
8
Signature Financial Management
Norfolk,
Virginia
| $21K | – | – | – |
|
|
AG
9
Advisor Group
Phoenix,
Arizona
| $7K | – | – | – |
|
|
10
UBS Group
Zurich,
Switzerland
| $4K | -$6.21K | -3 | -60% |
|
|
ST
11
Smithfield Trust
Pittsburgh,
Pennsylvania
| $3K | +$4.14K | +2 | New |
|
12
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $2K | – | – | – |
|
|
PVI
13
Pura Vida Investments
New York
| – | -$193K | -74 | Closed |
|
CRVO Hedge Fund Activity: Q3 2017 in Review
12 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q3 2017, worth a combined $1.86M — down 26% from $2.51M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CRVO positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $108K. The largest seller was Pura Vida Investments, exiting entirely with an estimated $193K sold.
- 12 institutional investors held CervoMed (CRVO) as of Q3 2017, up from 10 in Q2 2017.
- Funds reported $1.86M of CervoMed stock for Q3 2017, down 26% quarter-over-quarter.
- 4 funds opened new CervoMed positions in Q3 2017 and 1 closed out, a net change of +3 holders.
- The largest CervoMed buyer in Q3 2017 was Virtu Financial, an estimated $108K added.
- The largest CervoMed seller in Q3 2017 was Pura Vida Investments, an estimated $193K sold.
Based on aggregated 13F filings for Q3 2017.